- Home
- GSK vs SAN Comparison
GSK vs SAN Comparison
Compare GSK & SAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSK
- SAN
- Stock Information
- Founded
- GSK 1715
- SAN 1857
- Country
- GSK United Kingdom
- SAN Spain
- Employees
- GSK N/A
- SAN N/A
- Industry
- GSK Biotechnology: Pharmaceutical Preparations
- SAN Commercial Banks
- Sector
- GSK Health Care
- SAN Finance
- Exchange
- GSK Nasdaq
- SAN Nasdaq
- Market Cap
- GSK 76.5B
- SAN 73.2B
- IPO Year
- GSK N/A
- SAN 1987
- Fundamental
- Price
- GSK $33.33
- SAN $4.74
- Analyst Decision
- GSK Hold
- SAN Buy
- Analyst Count
- GSK 5
- SAN 1
- Target Price
- GSK $45.50
- SAN N/A
- AVG Volume (30 Days)
- GSK 8.2M
- SAN 3.1M
- Earning Date
- GSK 10-30-2024
- SAN 10-29-2024
- Dividend Yield
- GSK 4.67%
- SAN 4.52%
- EPS Growth
- GSK N/A
- SAN 21.62
- EPS
- GSK 0.81
- SAN 0.83
- Revenue
- GSK $41,966,224,352.00
- SAN $53,301,360,675.00
- Revenue This Year
- GSK $6.50
- SAN N/A
- Revenue Next Year
- GSK $4.54
- SAN $1.03
- P/E Ratio
- GSK $20.03
- SAN $5.51
- Revenue Growth
- GSK 5.59
- SAN 8.26
- 52 Week Low
- GSK $32.83
- SAN $3.83
- 52 Week High
- GSK $45.93
- SAN $5.27
- Technical
- Relative Strength Index (RSI)
- GSK 24.28
- SAN 44.29
- Support Level
- GSK $33.19
- SAN $4.60
- Resistance Level
- GSK $33.79
- SAN $4.88
- Average True Range (ATR)
- GSK 0.48
- SAN 0.07
- MACD
- GSK -0.19
- SAN -0.00
- Stochastic Oscillator
- GSK 11.63
- SAN 33.33
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
About SAN Banco Santander S.A. Sponsored ADR (Spain)
Santander's focus is on retail and commercial banking. Latin America is geographically the most significant operation, with Brazil making the largest contribution. Its continental European business is mainly in Spain and Portugal. Santander's UK presence is the result of its acquisition of Abbey building society. In the US, Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.